Statin-associated rhabdomyolysis triggered by grapefruit consumption
Abstract
A 40-year-old woman was admitted to the emergency room for bilateral lower extremity weakness. She had been exercising regularly in a gym, including workout and aerobics, and skydived regularly. She had felt perfectly healthy until 10 days earlier when she noticed slight muscle weakness and myalgia that increased gradually. Examination revealed bilateral proximal leg weakness, although muscle strength in the face, neck, arms, and distal legs was normal. Walking distance was <20 meters. Initial laboratory studies revealed dramatically increased serum levels of creatine kinase (12,640 U/L), myoglobin (6,453 μg/L), aspartate aminotransferase (623 U/L), and alanine aminotransferase (700 U/L), suggesting rhabdomyolysis. Serum electrolytes and renal function were normal. The patient was taking simvastatin (80 mg/d taken at bedtime) for hypercholesterolemia related to a heterozygous familial defective apolipoprotein B100 mutation. Statin-associated rhabdomyolysis was assumed, and simvastatin was discontinued. …
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Simvastatin has no specific requirement to be taken with or without food but has the potential to be toxic when taken concurrently with grapefruit juice.
“This is because whilst drugs such as simvastatin have no specific requirement to be taken with or without food it has the potential to be toxic when taken concurrently with grapefruit juice [186].”
From ESPEN guideline on nutritional support for polymorbid medical inpatients (2023) · cites this paper as [186]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 8 · Cited by 81
- Authors
- Dreier, J. P., & Endres, M.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Venue
- Neurology
- Published
- 2004-02-24
- Volume
- 62
- Issue
- 4
- Pages
- 670-670
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2001283681
- Cited by
- 81
- References
- 8
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 3 · 2013: 3 · 2012: 7
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Muscle and Compartmental Disorders
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Epidemiology › Inflammatory Myopathies and Dermatomyositis
- Keywords
- grapefruit, simvastatin, drug-drug interactions, creatine kinase elevation, myalgia, hypercholesterolemia, statin adverse effects
- MeSH terms
- Adult, Anticholesteremic Agents, Enzyme Inhibitors, Female, Humans, Hyperlipoproteinemia Type II, Inactivation, Metabolic, Furocoumarins, Rhabdomyolysis, Simvastatin, Citrus paradisi, Cytochrome P-450 CYP3A, Cytochrome P-450 Enzyme Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review